L
Lukas Tometten
Researcher at University of Cologne
Publications - 15
Citations - 320
Lukas Tometten is an academic researcher from University of Cologne. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 8 publications receiving 104 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry
Maria Rüthrich,C. Giessen-Jung,Stefan Borgmann,Annika Y. Classen,Sebastian Dolff,Beate Grüner,Frank Hanses,Nora Isberner,Philipp Köhler,Julia Lanznaster,Uta Merle,Silvio Nadalin,Christiane Piepel,J. Schneider,J. Schneider,M. Schons,R. Strauss,Lukas Tometten,Jorg-Janne Vehreschild,Jorg-Janne Vehreschild,M. von Lilienfeld-Toal,Gernot Beutel,Kai Wille +22 more
TL;DR: In this paper, the authors present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk.
Journal Article
COVID-19 in cancer patients: Clinical characteristics and outcome - a first analysis of the LEOSS registry
Maria Madeleine Ruethrich,G. Kniele,Lukas Tometten,Stefan Borgmann,J. Schneider,Sebastian Dolff,Frank Hanses,J. Norma,N. Isberner,M. Wettstein,Annika Y. Classen,M. Schons,Jorg-Janne Vehreschild,C. Giessen-Jung,Gernot Beutel,M. von Lilienfeld-Toal,Kai Wille +16 more
TL;DR: Comparing cancer and non-cancer patients, outcome of COVID-19 was comparable after adjusting for age, sex, and comorbidity, but cancer patients as a group are at higher risk due to advanced age and pre-existing conditions.
Journal ArticleDOI
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Carolin Jakob,Stefan Borgmann,Fazilet Duygu,Uta Behrends,Martin Hower,Uta Merle,Anette K. Friedrichs,Lukas Tometten,Frank Hanses,Norma Jung,Siegbert Rieg,Kai Wille,Beate Grüner,Hartwig Klinker,Nicole Gersbacher-Runge,Kerstin Hellwig,Lukas Eberwein,Sebastian Dolff,Dominic Rauschning,Michael von Bergwelt-Baildon,Julia Lanznaster,Richard Strauß,Janina Trauth,Maria Madeleine Ruethrich,Catherina Lueck,Jacob Nattermann,Lene Tscharntke,Lisa Pilgram,Sandra Fuhrmann,Annika Y. Classen,Melanie Stecher,M. Schons,Christoph D. Spinner,Jörg Janne Vehreschild,Jörg Janne Vehreschild +34 more
TL;DR: The LEOSS cohort identified age, cardiovascular disease, diabetes and male sex as risk factors for complicated disease stages at SARS-CoV-2 diagnosis, thus confirming previous data.
Journal ArticleDOI
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS).
Nina N. Kleineberg,Nina N. Kleineberg,Samuel Knauss,Eileen Gülke,Hans O. Pinnschmidt,Carolin Jakob,Paul Lingor,Kerstin Hellwig,Achim Berthele,Günter U. Höglinger,Günter U. Höglinger,Gereon R. Fink,Gereon R. Fink,Matthias Endres,Christian Gerloff,Christine Klein,Melanie Stecher,Annika Y. Classen,Siegbert Rieg,Stefan Borgmann,Frank Hanses,Maria Rüthrich,Martin Hower,Lukas Tometten,Martina Haselberger,Christiane Piepel,Uta Merle,Sebastian Dolff,Christian Degenhardt,Björn-Erik Ole Jensen,Maria J G T Vehreschild,Johanna Erber,Christiana Franke,Clemens Warnke +33 more
TL;DR: In this paper, the effects of prior neurological diseases and the effect of neurological symptoms on outcome were studied using multivariate logistic regression using real-world data from a multinational registry.
Journal ArticleDOI
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry.
Sebastian Cremer,Carolin Jakob,Alexander Berkowitsch,Stefan Borgmann,Lisa Pilgram,Lukas Tometten,Annika Y. Classen,Kai Wille,Simon Weidlich,Beate Gruener,Stefanie Dimmeler,Steffen Massberg,Siegbert Rieg,Andreas M. Zeiher +13 more
TL;DR: Starting targeted anti-inflammatory therapy and aggressive anticoagulation already in the uncomplicated phase of the disease might improve outcomes after SARS-CoV-2 infection in patients with cardiovascular comorbidities.